Spontaneous vs Controlled Mechanical Ventilation in Acute Hypoxemic Respiratory Failure
Official title: Spontaneous Versus Controlled Mechanical Ventilation in Patients With Acute Hypoxemic Respiratory Failure: A Feasibility Study and Pilot Trial
Run by Oslo University Hospital · NCT07463885 · Data updated 2026-11-12
This study tests whether allowing spontaneous breathing or using controlled ventilation is better for adults with acute hypoxemic respiratory failure who need invasive mechanical ventilation.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 80 (estimated) |
| Sponsor | Oslo University Hospital Academic / other |
| Locations | 1 site (Oslo, Oslo) |
| Status | Recruiting |
| Started | September 1, 2026 |
| Main results expected | September 1, 2027 |
| Study ends | March 30, 2028 |
| Registry record updated | October 15, 2026 |
| Trial ID | NCT07463885 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults (18+) in the ICU on invasive mechanical ventilation for less than 24 hours with moderate acute hypoxemic respiratory failure (PaO2/FiO2 100–200 mmHg, PEEP ≥5) and new pulmonary infiltrates.
✕Probably not a fit
Patients with advanced lung injury where spontaneous breathing may be harmful or those not meeting the exact respiratory criteria may not benefit from this approach.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
The SVALBARD trial is a feasibility and pilot study comparing spontaneous ventilation to controlled ventilation in adults with acute hypoxemic respiratory failure at risk of ARDS. It aims to determine whether the study procedures, interventions, and data collection are workable in this population and to describe key clinical variables to plan a future randomized trial. The trial builds on current lung-protective ventilation concepts and examines potential physiological and clinical implications of preserving spontaneous breathing during ventilation. Results will inform design choices for a larger, definitive study and help clarify the balance of risks and benefits for different ventilation strategies.
Why it matters
Potential benefit: If successful, the trial could pave the way for a ventilation approach that reduces sedation needs, frees breathing effort, and optimizes outcomes for patients with acute hypoxemic respiratory failure.
How similar studies have gone: Previous observational work suggests potential benefits of spontaneous breathing, but randomized controlled data are limited, making this feasibility study an important step.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: We will include patients who fulfil all the following criteria: * Acutely admitted to the ICU * AND age ≥ 18 years * AND invasive mechanical ventilation via endotracheal tube or tracheostomy for less than 24 hours * AND moderate acute hypoxemic respiratory failure, defined as a PaO₂-FiO₂ ratio between 13.3-26.6 kPa (100-200 mmHg) with PEEP ≥ 5 cm H2O, based on arterial blood gas analysis obtained within 2 hours before randomisation. * AND new pulmonary infiltrate (uni- or bilateral) on chest x-ray or CT-scan obtained no more than 24 hours before randomisation. Exclusion Criteria: * Previously randomised into the SVALBARD trial. * Informed consent following inclusion expected to be unobtainable * Patient under coercive measures * Withdrawal from active therapy or brain death deemed imminent. * Chronic hypercapnic respiratory failure defined as PaCO2 \> 8 kPa (60 mm Hg) in the outpatient setting. * Listed for lung transplant. * Acute heart failure / acute myocardial infarction / cardiac arrest during or causing index ICU admission. * Use of home oxygen. * Chronic mechanical ventilation for any reason except for non-invasive mechanical ventilation (CPAP/BIPAP) used solely for sleep apnoea disorder. * Currently receiving ECMO therapy. * Burns \>70 % total body surface. * Acute brain injury or stroke (any, including subarachnoid haemorrhage, SAH). * Intracranial hypertension. * Patients with planned repeat surgical interventions during current stay in ICU.
Where it's running
-
Oslo University Hospital - Rikshospitalet
Oslo, Oslo, Norway Recruiting
Study contacts
- Study coordinator: Jon Henrik Laake, MD, PHD
- Email: jlaake@ous-hf.no
- Phone: 0047 97660919
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Using Electrical Impedance Tomography to Optimize Ventilator Settings in Patients with Severe Breathing Problems
This study is trying to see if using a special imaging technique can help set ventilators better for patients with severe breathing problems like acute respiratory failure.
-
Understanding immune patterns and ECMO strategies to help adults with severe ARDS
This study tests how different immune and clinical patterns in adults with moderate-to-severe ARDS respond to ECMO and lung-protective care, aiming to improve outcomes.
-
Optimal corticosteroid dosing for ARDS: short vs. prolonged therapy
This trial tests different corticosteroid doses and treatment lengths to see which helps adults with ARDS who are on ventilators.
-
Lateral positioning to optimize breathing in adults after abdominal surgery with ARDS
This study tests whether lying on the left or right side helps improve lung function in adults who developed ARDS after abdominal surgery, using a bedside imaging test to watch ventilation and blood flow while changing positions.
-
Predicting HFNC Failure in Acute Hypoxemic Respiratory Failure using Metabolomics and Clinical Data
This study tests whether metabolomic blood profiles combined with routine clinical data can predict which adults with acute hypoxemic respiratory failure on high-flow nasal cannula will fail and need escalation of care.
-
Dexamethasone for sepsis-related ARDS in adults on ventilatory support
This trial tests whether dexamethasone can help adults with sepsis-associated ARDS on ventilators recover better compared to placebo.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.